How to synthesize and analyze the very large amount of data reported weekly by sales teams in the pharmaceutical industry? This is the challenge raised by a major player in the European healthcare sector, which recognizes how valuable this data, rich in insights, is for the strategic management of its business in both the short and long term.
To respect professional secrecy and confidentiality agreements, the identity of our clients and certain technical details are intentionally anonymized. We primarily work on strategic, high-value-added innovation projects, for which discretion is essential to preserving our clients' competitive advantage.
The integration of advanced generative AI capabilities represents a major opportunity not only to simplify but also to automate the analysis and use of this type of information. It is on this synthesis aspect that this company chose to focus its efforts. Raw files were thus used to properly populate the LLM and define the semantic field specific to this client's context. From this database, an initial analysis of the extracted and processed content could be conducted to assess its relevance and value.
Our teams initially designed an automated data transformation process to:
Following the initial analysis, our teams were able to implement:
This type of project is exciting and promising. Exciting because it shows us the vast potential of generative AI, regardless of the sector or the problem identified. Promising because the results are tangible and measurable very quickly. To scale up, all stakeholders will need to get involved at several levels (technical, technological, business, etc.), but the enthusiasm and expectations are clear!
Guillaume Lanthier
AI Factory Manager, Smile